Skip to content

Opening book details…

About this Medicine article

Phase II Trial of a Single Weekly Intravenous Dose of Ranpirnase in Patients With Unresectable Malignant Mesothelioma by Mikulski, Stanislaw M.; Costanzi, John J.; Vogelzang, Nicholas J.; McCachren, Spence; Taub, Robert N.; Chun, Hoo; Mittelman, Abraham; Panella, Timothy; Puccio, Carmelo; Fine, Robert; Shogen, Kuslima is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Mikulski, Stanislaw M.; Costanzi, John J.; Vogelzang, Nicholas J.; McCachren, Spence; Taub, Robert N.; Chun, Hoo; Mittelman, Abraham; Panella, Timothy; Puccio, Carmelo; Fine, Robert; Shogen, Kuslima
Publisher
American Society of Clinical Oncology; American Society of Clinical Oncology (ASCO) (ISSN 0732-183X)
Published
2002
Language
EN
Field
Medicine (Health Sciences)

More by Mikulski, Stanislaw M.; Costanzi, John J.; Vogelzang, Nicholas J.; McCachren, Spence; Taub, Robert N.; Chun, Hoo; Mittelman, Abraham; Panella, Timothy; Puccio, Carmelo; Fine, Robert; Shogen, Kuslima

Browse all works by Mikulski, Stanislaw M.; Costanzi, John J.; Vogelzang, Nicholas J.; McCachren, Spence; Taub, Robert N.; Chun, Hoo; Mittelman, Abraham; Panella, Timothy; Puccio, Carmelo; Fine, Robert; Shogen, Kuslima